ABT Earnings Abbott Laboratories
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q1 2026 | 2026-03-31 | 0.61 | 2026-04-29 | 10-Q |
| FY 2025 | 2025-12-31 | 3.72 | 2026-02-20 | 10-K |
| Q3 2025 | 2025-09-30 | 2.70 | 2025-10-29 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.77 | 2025-07-30 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.76 | 2026-04-29 | 10-Q |
| FY 2025 | 2024-12-31 | 7.64 | 2026-02-20 | 10-K |
| Q3 2025 | 2024-09-30 | 2.38 | 2025-10-29 | 10-Q |
| Q2 2025 | 2024-06-30 | 1.44 | 2025-07-30 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.70 | 2025-04-30 | 10-Q |
| FY 2025 | 2023-12-31 | 3.26 | 2026-02-20 | 10-K |
| Q3 2024 | 2023-09-30 | 2.35 | 2024-10-31 | 10-Q |
| Q2 2024 | 2023-06-30 | 1.53 | 2024-07-31 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.75 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | 3.91 | 2025-02-21 | 10-K |
| Q3 2023 | 2022-09-30 | 3.32 | 2023-11-01 | 10-Q |
| Q2 2023 | 2022-06-30 | 2.51 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | 1.37 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | 3.94 | 2024-02-16 | 10-K |
| Q3 2022 | 2021-09-30 | 2.83 | 2022-11-01 | 10-Q |
| Q2 2022 | 2021-06-30 | 1.66 | 2022-08-02 | 10-Q |
| Q1 2022 | 2021-03-31 | 1.00 | 2022-05-03 | 10-Q |
| FY 2022 | 2020-12-31 | 2.50 | 2023-02-17 | 10-K |
| Q3 2021 | 2020-09-30 | 1.30 | 2021-11-03 | 10-Q |
| Q2 2021 | 2020-06-30 | 0.61 | 2021-08-04 | 10-Q |
| Q1 2021 | 2020-03-31 | 0.31 | 2021-05-05 | 10-Q |
| FY 2021 | 2019-12-31 | 2.06 | 2022-02-18 | 10-K |
| Q3 2020 | 2019-09-30 | 1.47 | 2020-11-04 | 10-Q |
| Q2 2020 | 2019-06-30 | 0.94 | 2020-07-29 | 10-Q |
| Q1 2020 | 2019-03-31 | 0.38 | 2020-04-29 | 10-Q |
| FY 2020 | 2018-12-31 | 1.33 | 2021-02-19 | 10-K |
| FY 2019 | 2018-09-30 | 0.32 | 2020-02-21 | 10-K |
| FY 2019 | 2018-06-30 | 0.41 | 2020-02-21 | 10-K |
| FY 2019 | 2018-03-31 | 0.23 | 2020-02-21 | 10-K |
| FY 2019 | 2017-12-31 | 0.27 | 2020-02-21 | 10-K |
| FY 2018 | 2017-09-30 | 0.34 | 2019-02-22 | 10-K |
| FY 2018 | 2017-06-30 | 0.16 | 2019-02-22 | 10-K |
| FY 2018 | 2017-03-31 | 0.24 | 2019-02-22 | 10-K |
| FY 2018 | 2016-12-31 | 0.94 | 2019-02-22 | 10-K |
| FY 2017 | 2016-09-30 | -0.22 | 2018-02-16 | 10-K |
| FY 2017 | 2016-06-30 | 0.41 | 2018-02-16 | 10-K |
| FY 2017 | 2016-03-31 | 0.21 | 2018-02-16 | 10-K |
| FY 2017 | 2015-12-31 | 2.92 | 2018-02-16 | 10-K |
| FY 2016 | 2015-09-30 | 0.38 | 2017-02-17 | 10-K |
| FY 2016 | 2015-06-30 | 0.52 | 2017-02-17 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.